Shuichi Kaneko
Kanazawa University
900 Papers
5.7K Citations
Shuichi Kaneko is an academic researcher from Kanazawa University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 86, co-authored 842 publications. Previous affiliations of Shuichi Kaneko include Kaneka Corporation & Tottori University.
Chat about Author
Papers
The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?
Tomoyuki Hayashi,Tomoyuki Hayashi,Yumie Takeshita,Yumie Takeshita,Yvan J.F. Hutin,Hande Harmanci,Philippa Easterbrook,Sarah Hess,Judith van Holten,Ena Oru,Shuichi Kaneko,Cihan Yurdaydin,Marc Bulterys +12 more
TL;DR: In this paper, the authors performed a literature review in terms of epidemiology by WHO regions, genotypes distribution and their pathogenicity, factors associated with hepatitis delta virus infection, mortality due to HDV infection, testing strategies and treatment.
Antitumor Effect after Radiofrequency Ablation of Murine Hepatoma Is Augmented by an Active Variant of CC Chemokine Ligand 3/Macrophage Inflammatory Protein-1α
Noriho Iida,Yasunari Nakamoto,Tomohisa Baba,Hidetoshi Nakagawa,Eishiro Mizukoshi,Makoto Naito,Naofumi Mukaida,Shuichi Kaneko +7 more
TL;DR: It is proved that ECI301 further augments RFA-induced antitumor immune responses in a CCR1-dependent manner in IFN-gamma-enzyme-linked immunospot assay.
S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species
Noriko Takuwa,Sei Ichiro Ohkura,Shin Ichiro Takashima,Keisuke Ohtani,Yasuo Okamoto,Tamotsu Tanaka,Kaoru Hirano,Soichiro Usui,Fei Wang,Wa Du,Kazuaki Yoshioka,Yoshiko Banno,Motoko Sasaki,Ikuyo Ichi,Miwa Okamura,Naotoshi Sugimoto,Kiyomi Mizugishi,Yasuni Nakanuma,Isao Ishii,Masayuki Takamura,Shuichi Kaneko,Shosuke Kojo,Kiyoshi Satouchi,Kunitoshi Mitumori,Jerold Chun,Yoh Takuwa +25 more
TL;DR: It is suggested that chronic activation of SPHK1-S1P signalling results in both pathological cardiac remodelling through ROS mediated by S1P3 and favourable cardioprotective effects.
Adipose tissue-derived stem cells as a regenerative therapy for a mouse steatohepatitis-induced cirrhosis model
Akihiro Seki,Yoshio Sakai,Takuya Komura,Alessandro Nasti,Keiko Yoshida,Mami Higashimoto,Masao Honda,Soichiro Usui,Masayuki Takamura,Toshinari Takamura,Takahiro Ochiya,Kengo Furuichi,Takashi Wada,Shuichi Kaneko +13 more
TL;DR: Gene expression analysis of the liver identifies up‐ and down‐regulation of genes, indicating regeneration/repair and anti‐inflammatory processes following ADSC injection, and suggests that ADSC therapy is beneficial in cirrhosis, as it can repair and restore the function of the impaired liver.
Phase I trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinoma.
Eishiro Mizukoshi,Hidetoshi Nakagawa,Masaaki Kitahara,Tatsuya Yamashita,Kuniaki Arai,Hajime Sunagozaka,Noriho Iida,Kazumi Fushimi,Shuichi Kaneko +8 more
TL;DR: The safety, effects of immune boosting, and possible prolongation of overall survival by the MRP3-derived peptide demonstrate the potential of the peptide to provide clinical benefit in HCC patients.